Suzanne Somers’ Legacy Tainted by Celebrity Medical Misinformation
The popular actress and author, who died this week, also can be remembered as a progenitor of selling dubious medical information to a trusting public.
The independent source for health policy research, polling, and news.
61 - 80 of 225 Results
The popular actress and author, who died this week, also can be remembered as a progenitor of selling dubious medical information to a trusting public.
A breast cancer patient who received similar treatments in two states saw significant differences in cost, illuminating how care in remote areas can come with a stiffer price tag.
Federal research linking “forever chemicals” to testicular cancer confirms what U.S. military personnel long suspected. But as they seek testing for PFAS exposure, many wonder what to do with the results. There’s no medical treatment yet.
Mississippi has among the highest cervical cancer mortality rates in the U.S. When low-income women can't afford regular preventive care, much less gynecological visits, this highly preventable and treatable cancer becomes a killer.
The first of a new wave of cancer-detection blood tests likely saved Gilbert Milam Jr.’s life. But many cancer researchers, wary of overtesting, argue it’s premature to prescribe the Galleri test widely.
The military first documented health concerns surrounding chemicals known as PFAS decades ago yet has continued to use firefighting foam made with them. Despite scores of lawsuits by its personnel and high rates of testicular cancer among troops, it has been slow to investigate a connection.
Social and economic pressures have long compelled Black girls and women to straighten their hair. But mounting evidence shows chemical straighteners — products with little regulatory oversight — may pose cancer and other health risks.
Kristie Fields, a cancer patient in Virginia, was urged to go public to seek financial help. She worried about feeding hurtful stereotypes.
A quality-control crisis at an Indian pharmaceutical factory has left doctors and their patients with impossible choices as cheap, effective, generic cancer drugs go out of stock.
The federal government’s arcane process for medical coding is influencing which reconstructive surgery options are available, creating anxiety for breast cancer patients.
There is no direct evidence that screening women in their 40s will save lives, yet modeling suggests expanding routine mammography to include them might avert 1.3 deaths per 1,000. Highlighting the risk of false positives, some specialists call for a more personalized approach.
Young cancer patients must act quickly to preserve their sperm and eggs once they get their diagnosis, and many can’t afford the cost.
When uninsured people are diagnosed with cancer, accessing resources and paying for treatment can be daunting. The safety nets meant to help often fall short, say cancer physicians and health policy experts who study access to care. Some patients find it easier to play the odds.
A U.S. District Court ruling overturned the section of the Affordable Care Act that makes preventive health services — from colonoscopies to diabetes screenings and more — available at no cost to consumers.
Medi-Cal serves more than one-third of the state’s population — offering a dizzying range of care to a diverse population. In the new “Faces of Medi-Cal” series, California Healthline will assess the program’s strengths and weaknesses through the lives and experiences of its enrollees.
When Medicare stops paying for a pricey drug that prolongs life, an Ohio man considers giving up treatment to spare his family enormous debt.
The proportion of Californians dying at home, rather than in a hospital or nursing home, accelerated during the pandemic, a trend that has outlasted the rigid lockdowns linked to the initial shift.
When Penelope Wingard's cancer went into remission, she lost her Medicaid coverage in North Carolina. Without insurance, the debts piled up for her follow-up care. She doesn't think she'll ever get ahead of it.
Monica Reed was the first in her family to own a home and has lived "a frugal kind of life." Cancer treatment left her with almost $10,000 in debt, pushing her to the edge financially.
Improving lung cancer outcomes in Black communities will take more than lowering the screening age, experts say. Disparities are present in everything from the studies that inform when people should get checked to the availability of care in rural areas.
© 2026 KFF